AGP Picks
View all

Informing on health and wellness news in Mississippi

Provided by AGP

Mississippi Healthcare Reporter
Got News to Share?
Got News to Share? globe Explore more publications!

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development
May 18, 2026

Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development

Indeterminate GlobeNewswire
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
May 18, 2026

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Indeterminate GlobeNewswire
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Indeterminate GlobeNewswire
Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting
May 18, 2026

Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting

Indeterminate GlobeNewswire
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
May 18, 2026

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Indeterminate GlobeNewswire
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
May 18, 2026

Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications
May 18, 2026

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications

Indeterminate GlobeNewswire
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
May 18, 2026

Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development

Indeterminate GlobeNewswire
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 18, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
One Fire, Many Flames: The Immune Response Fueling Allergic and Inflammatory Diseases
May 18, 2026

One Fire, Many Flames: The Immune Response Fueling Allergic and Inflammatory Diseases

Indeterminate GlobeNewswire
Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
May 18, 2026

Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

Indeterminate GlobeNewswire
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 18, 2026

Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia

Indeterminate GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting
May 18, 2026

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting
May 18, 2026

SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
May 18, 2026

Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Mississippi Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.